EPAX AS, a leading global supplier of marine-derived EPA/DHA omega-3 fatty acids, has recently settled in its new headquarter facility, OmegaHus (OmegaHouse), to accommodate its nearly tripled staff during the past nine years.
Located on Norway's western shore, the three-story, approximately 16,000 square-foot operational facility is incorporated into the company's existing production site, research and development departments and quality assurance and control testing labs.
The completion of the year-long construction project allows EPAX to further reduce its environmental impact, as the new facility uses excess heat created from the nearby processing plant to warm its offices throughout the year and particularly during the long, dark winters typical of the region. The modern, Nordic-inspired structure also features large windows, translucent office walls and doors, and a light interior palette to reflect and preserve natural light throughout the facility.
In addition, the new building's layout was designed to create a collaborative work environment among employees who can now easily interact between departments, access the plant and labs and enjoy the on-site cantina.
"As EPAX AS has experienced significant growth during the past decade, our need for a larger administrative facility was necessary," said Bjorn Refsum, president and CEO of EPAX AS. "OmegaHus fosters interdepartmental communication and thereby further enhances our customer commitment to top-quality fish oils. We are pleased to incorporate several sustainable elements into its design and operation. For example, the building's energy consumption has been reduced by 50 percent and the construction material is natural and non- allergic. We look forward to it providing our employees and visiting customers a brick-and-mortar representative of our commitment to purity, quality and innovation."
About EPAX AS
EPAX AS offers concentrated marine omega-3 oils in the business-to- business segment under the brand name EPAX®, available in a wide range of top-quality formulas with different EPA/DHA ratios and concentrations focused on specific health conditions, available in TG and EE versions. EPAX AS is headquartered in Aalesund with a global sales office in Lysaker/Oslo, Norway. Its production facility in Aalesund is GMP-approved by the Norwegian Medicines Agency for the manufacturing of API products. EPAX is part of the Austevoll Seafood ASA group – a globally integrated pelagic fishery specialist with operations in Chile, Norway and Peru (www.auss.no). All of EPAX’s business efforts reflect the company's core commitment: Purity | Quality | Innovation. These values represent EPAX's commitment to offering products that are safe, pure and of consistent quality. EPAX® specifications limits for environmental pollutants and oxidation by- products are well below those set by global authorities' limits. All EPAX formulas are backed by clinical studies.